BlackRock Investment Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

BlackRock Investment Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$557K	Buy	115,285 +507	+0.4%	+$15.1K	﹤0.01%	3014
2016 Q3	$5.29M	Buy	114,778 +1,003	+0.9%	+$56.6K	0.01%	1438
2016 Q2	$5.81M	Buy	113,775 +31,350	+38%	+$1.56M	0.01%	1337
2016 Q1	$3.48M	Buy	82,425 +2,741	+3%	+$140K	﹤0.01%	1617
2015 Q4	$6.26M	Buy	79,684 +39	+0%	+$2.25K	0.01%	1242
2015 Q3	$3.23M	Sell	79,645 -317	-0.4%	-$16.8K	﹤0.01%	1692
2015 Q2	$4.16M	Buy	79,962 +41,808	+110%	+$2.08M	0.01%	1641
2015 Q1	$1.77M	Buy	38,154 +663	+2%	+$34.4K	﹤0.01%	2114
2014 Q4	$1.68M	Sell	37,491 -482	-1%	-$20.2K	﹤0.01%	2161
2014 Q3	$1.48M	Buy	37,973 +51	+0.1%	+$2K	﹤0.01%	2227
2014 Q2	$1.6M	Buy	37,922 +11,046	+41%	+$405K	﹤0.01%	2261
2014 Q1	$959K	Buy	26,876 +3,108	+13%	+$105K	﹤0.01%	2530
2013 Q4	$769K	Buy	+23,768	New	+$705K	﹤0.01%	2699

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock Investment Management's ISEE Position: Q4 2016 in Review

BlackRock Investment Management increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 0.44% in Q4 2016, buying an estimated $15.1K and bringing the position to 115,285 shares worth $557K. The position accounts for ﹤0.01% of the portfolio, ranked #3014.

BlackRock Investment Management first reported a position in ISEE in Q4 2013 and has held it in 13 quarters since. The position peaked at $6.26M in Q4 2015. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

BlackRock Investment Management held 115,285 shares of IVERIC bio, Inc. Common Stock worth $557K as of Q4 2016.
BlackRock Investment Management bought 507 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $15.1K.
IVERIC bio, Inc. Common Stock made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3014 holding.
BlackRock Investment Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and has held it in 13 quarters since.
BlackRock Investment Management's IVERIC bio, Inc. Common Stock position peaked at $6.26M in Q4 2015.
137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.